Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis.
D000081:Acetamides / Q000008:administration & dosage; D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D005260:Female; D024841:Fluoroquinolones / Q000008:administration & dosage; D000077734:Gatifloxacin; D007538:Isoniazid / Q000008:administration & dosage; D000069349:Linezolid; D051379:Mice; D008810:Mice, Inbred C57BL; D023303:Oxazolidinones / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology
D000081:Acetamides; D000995:Antitubercular Agents; D024841:Fluoroquinolones; D023303:Oxazolidinones; D000069349:Linezolid; D000077734:Gatifloxacin; D007538:Isoniazid; D012293:Rifampin